Navigation Links
Orexigen(R) Therapeutics Presents Additional NB-302 Contrave(R) Data at American Diabetes Association (ADA) 69th Scientific Sessions
Date:6/6/2009

, which we believe meet the FDA efficacy guidance at the more stringent 10% threshold, also provide further support of Contrave's potential as a weight loss treatment for clinicians and their obese patients."

The overall discontinuation rate due to adverse events in NB-302 was 25.9% for patients taking Contrave versus 13.0% for those taking placebo. The most frequently observed adverse events leading to discontinuation for patients on study drug were nausea, urticaria (hives) and anxiety.

Contrave was generally well tolerated, with an overall safety profile consistent with its individual components, naltrexone and bupropion, two drugs that have been used separately for over 20 years. The discontinuation rate due to nausea was 4.6%. This rate is lower than what was seen in the Phase 2 trial (NB-201), which utilized the immediate release formulation of naltrexone as opposed to the proprietary SR formulation used in this trial. The most frequently observed treatment-emergent adverse events for patients on study drug were nausea, headache, constipation and dizziness.

About Contrave(R)

Contrave is an investigational oral weight loss medication with a unique mechanism of action that works at two levels within the central nervous system: one associated with controlling the balance of food intake and metabolism and another involved in controlling food preference, reward and cravings. We believe that Contrave may be the first treatment for obesity to target these reward centers in the central nervous system. Based on clinical trials completed to date, Contrave is believed to initiate and sustain significant weight loss over one year of treatment by reducing appetite, increasing metabolism and allowing the body to continue losing weight by offsetting its natural tendency to fight back and slow down the weight loss process.

About Orexigen(R) Therapeutics

Orexige
'/>"/>

SOURCE Orexigen Therapeutics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Orexigen(R) Therapeutics Announces Upcoming Data Presentations at American Diabetes Association and Endocrine Society Annual Scientific Meetings
2. Orexigen(R) Therapeutics to Present at Upcoming Meetings
3. Orexigen(R) Therapeutics Announces Jay Hagan as Senior Vice President, Corporate Development and Strategy
4. Orexigen(R) Therapeutics to Speak at Upcoming Conferences
5. Orexigen(R) Therapeutics Announces First Quarter 2009 Financial Results
6. Orexigen(R) Therapeutics Names Michael Scaife Senior Vice President of Regulatory Affairs and Product Development, Contrave(R) Program
7. Orexigen(R) Therapeutics Schedules March 12, 2009 Webcast Discussion of Financial Results for the Fourth Quarter and Year Ended December 31, 2008
8. Orexigen(R) Therapeutics to Speak at BIO CEO & Investor Conference
9. Orexigen(R) Therapeutics Announces First of Four Phase 3 Trials of Contrave(R) Meets Co-Primary and Key Secondary Endpoints
10. Orexigen(R) Therapeutics Issued a Key Fourth U.S. Patent on Contrave(R)
11. Orexigen(R) Therapeutics Announces Third Quarter 2008 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2014)... PARSIPPANY, N.J. , Aug. 31, 2014 ... New Drug Discovery program in Anti-Infective research when two ... the coveted Qualified Infectious Disease Product (QIDP) status from ... granted to drugs which act against pathogens which have ... and are identified by Centre for Disease Control (a ...
(Date:8/31/2014)... Available spectra is similar for all L-series ... of a wide range of plants. The spectra ... patented and pending wide spectrum technology. The single ... applications in contrast to growth spectra made from ... a large variety of differently sized and shaped ...
(Date:8/31/2014)... 2014 2014 Market Research ... professional and in-depth research report on the ... information, including Polyacrylamide definition, classification, application, and ... overview. This research covers the international market ... global industry analysis covering macroeconomic environment & ...
(Date:8/31/2014)... 2014 This is a professional ... the Epoxy Hardener industry in Global and ... the industry, including definitions, applications and industry chain ... analysis are provided with a focus on history, ... A comparison between the international and Chinese situation ...
Breaking Biology Technology:U.S. FDA Grants QIDP Status for Wockhardt Anti-Infective Drug Discovery Program 2U.S. FDA Grants QIDP Status for Wockhardt Anti-Infective Drug Discovery Program 3International Polyacrylamide Industry & Copper Iodide Market Data Analysis Now Available at DeepResearchReports.com 2International Polyacrylamide Industry & Copper Iodide Market Data Analysis Now Available at DeepResearchReports.com 3Epoxy Hardener Industry Development Trends in Global & China Regions Now Available at ReportsnReports.com 2Epoxy Hardener Industry Development Trends in Global & China Regions Now Available at ReportsnReports.com 3
... Oct. 30 Prometheus Laboratories Inc., a,specialty ... U.S.,Patent and Trademark Office (USPTO) has issued ... Thiopurine Metabolites, a,diagnostic test that enables physicians ... and maintain desired therapeutic levels. The USPTO ...
... oncologist, discusses his breakthrough robotic surgery techniques, following an OR Live ... sexual function and continence. To date, Dr. Samadi has performed over ... his patients. , ... New York, NY (PRWEB) October ...
... Methylated DNA Quantification Kit significantly,simplifies the study of Global Methylation ... ... current methods, ST. LOUIS, Oct. ... Quantification Kit,(MDQ1) for epigenetic research http://www.sigma-aldrich.com/mdq1 . The,Methylated DNA ...
Cached Biology Technology:Prometheus Strengthens Intellectual Property Portfolio with Newly Issued Patents for Thiopurine Metabolite Testing 2Prominent Urologist Dr. David B. Samadi Presents Breakthrough Robotic Surgery Techniques on OR Live Webcast 2Prominent Urologist Dr. David B. Samadi Presents Breakthrough Robotic Surgery Techniques on OR Live Webcast 3Prominent Urologist Dr. David B. Samadi Presents Breakthrough Robotic Surgery Techniques on OR Live Webcast 4Sigma-Aldrich Introduces Methylated DNA Quantification Technology for Epigenetic Research 2Sigma-Aldrich Introduces Methylated DNA Quantification Technology for Epigenetic Research 3
(Date:8/31/2014)... at the University of Warwick have discovered that ,good, ... , The substance, methylglyoxal - MG, was found to ... bad cholesterol from the body. , Low levels ... heart disease, with increased levels of MG being common ... problems. , Supported by funding from the British ...
(Date:8/31/2014)... provides a fast and accurate tool to diagnose ... The newly developed test (TAM-TB assay) is the ... in children. The test features excellent specificity, a ... speed of a blood test. The promising findings ... tuberculosis in children, particularly in tuberculosis-endemic regions. , ...
(Date:8/31/2014)... the highly infectious bacteria C. diff , that ... by a team at the University of Leicester. , ... that it is possible to identify the unique ,smell, ... rapid diagnosis of the condition., What is more, the ... different strains of the disease simply from their smell ...
Breaking Biology News(10 mins):Sugar substance 'kills' good HDL cholesterol, new research finds 2New tuberculosis blood test in children is reliable and highly specific 2Scientists develop 'electronic nose' for rapid detection of C. diff infection 2
... the Gladstone Institutes and the Stanford University School of ... toxic buildup of a protein found in nerve cells. ... treating a variety of neurodegenerative conditions, including amyotrophic lateral ... which there is no cure. The Gladstone ...
... The ability of embryonic stem cells to differentiate into ... and maintained by a complex series of chemical interactions, ... process could prove useful for stem cell-based therapies down ... Carnegie,s Yixian Zheng zeroes in on the process by ...
... or mating or to capture bigger prey, but a University ... crab has a more self-serving social agenda: to kick another ... home., All hermit crabs appropriate abandoned snail shells for their ... crabs popular terrarium pets are the only ones ...
Cached Biology News:Gladstone, Stanford scientists block toxic protein that plays key role in Lou Gehrig's disease 2Gladstone, Stanford scientists block toxic protein that plays key role in Lou Gehrig's disease 3Solving stem cell mysteries 2Hermit crabs socialize to evict their neighbors 2Hermit crabs socialize to evict their neighbors 3
... mitochondrial transmembrane potential is one ... that occur following induction of ... Kit utilizes a lipophilic cation, ... mitochondrial activity marker. MitoLight partitions ...
Kit Components: Anti-Acetylated Histone H3 Salmon Sperm DNA/Protein A Agarose All necessary buffers. ...
Sf21 Insect Cells (Frozen) in Max-XP Medium...
... ChipWriter Pro system, 220-240 V, uses floating ... oligonucleotides, carbohydrates, lipids, and other biomolecules onto ... This system can generate high-density arrays with ... or greater than 57,000 spots per membrane ...
Biology Products: